164 related articles for article (PubMed ID: 11401666)
1. S100A6 expression in fibrohistiocytic lesions.
Fullen DR; Reed JA; Finnerty B; McNutt NS
J Cutan Pathol; 2001 May; 28(5):229-34. PubMed ID: 11401666
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
West KL; Cardona DM; Su Z; Puri PK
Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
[TBL] [Abstract][Full Text] [Related]
3. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
5. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
6. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
7. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
Franchi A; Santucci M
Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
[TBL] [Abstract][Full Text] [Related]
8. S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi.
Fullen DR; Reed JA; Finnerty B; McNutt NS
J Cutan Pathol; 2001 Sep; 28(8):393-9. PubMed ID: 11493376
[TBL] [Abstract][Full Text] [Related]
9. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
Fullen DR; Garrisi AJ; Sanders D; Thomas D
J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors.
Taniuchi K; Yamada Y; Nonomura A; Takehara K
J Cutan Pathol; 1997 Aug; 24(7):393-7. PubMed ID: 9274955
[TBL] [Abstract][Full Text] [Related]
11. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
Goldblum JR; Tuthill RJ
Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
[TBL] [Abstract][Full Text] [Related]
12. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ.
King R; Googe PB; Page RN; Mihm MC
Mod Pathol; 2005 Aug; 18(8):1043-7. PubMed ID: 15803191
[TBL] [Abstract][Full Text] [Related]
13. A unique biphasic variant of cutaneous fibrous histiocytoma with a storiform pattern and intralesional pigmented melanocytes: "storiform melano-fibrous histiocytoma".
Nair V; Weinreb I; MacNeil N; Szollosi Z; Chetty R; Ghazarian D
Eur J Dermatol; 2008; 18(3):332-6. PubMed ID: 18474466
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
15. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
Abenoza P; Lillemoe T
Am J Dermatopathol; 1993 Oct; 15(5):429-34. PubMed ID: 7694515
[TBL] [Abstract][Full Text] [Related]
16. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors.
Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST
Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167
[TBL] [Abstract][Full Text] [Related]
17. Fibrohistiocytic Tumors.
Romano RC; Fritchie KJ
Clin Lab Med; 2017 Sep; 37(3):603-631. PubMed ID: 28802503
[TBL] [Abstract][Full Text] [Related]
18. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.
McNiff JM; Subtil A; Cowper SE; Lazova R; Glusac EJ
J Cutan Pathol; 2005 Jul; 32(6):413-8. PubMed ID: 15953374
[TBL] [Abstract][Full Text] [Related]
19. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
20. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]